Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

57.1%

4 terminated/withdrawn out of 7 trials

Success Rate

42.9%

-43.6% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
6(85.7%)
Phase 3
1(14.3%)
7Total
N/A(6)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT00664768Not ApplicableCompleted

A Growth and Hypoallergenicity Study of a New Formula for Infants With Cow Milk Allergy

Role: lead

NCT03563391Not ApplicableCompleted

A Study to Evaluate the Effects of a New Formula on the Growth, Safety and Tolerance of Infants With Growth Failure

Role: lead

NCT01975766Not ApplicableTerminated

Ketogenic Diet Phase 1 for Head & Neck Cancer

Role: collaborator

NCT01419483Not ApplicableTerminated

Ketogenic Diet With Concurrent Chemoradiation for Pancreatic Cancer

Role: collaborator

NCT01419587Not ApplicableTerminated

Ketogenic Diet With Chemoradiation for Lung Cancer (KETOLUNG)

Role: collaborator

NCT01116388Not ApplicableCompleted

A Study to Assess the Role of a Gluten Free-dairy Free (GFCF) Diet in the Dietary Management of Autism Associated Gastrointestinal Disorders

Role: collaborator

NCT01016522Phase 3Terminated

Safety and Tolerability of the Ketogenic Diet in Amyotrophic Lateral Sclerosis (ALS)

Role: collaborator

All 7 trials loaded